Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Climacteric

• Publication date

  2013-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/13697137.2013.795683PMID 23672656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormone therapy and ovarian cancer.

  2015cited by this paper
• Pharmacological Treatment of Urinary Incontinence

  2014cited by this paper
• Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy

  2013cited by this paper
• Global Consensus Statement on menopausal hormone therapy.

  2013cited by this paper
• Global Consensus Statement on Menopausal Hormone Therapy

  2013cited by this paper
• The Kronos Early Estrogen Prevention Study

  2013cited by this paper
• A global consensus statement on menopause hormone therapy – aims, aspirations and action points

  2013cited by this paper
• Hormone therapy and Alzheimer disease dementia

  2012cited by this paper
• Colorectal cancer in women: hormone replacement therapy and chemoprevention

  2012cited by this paper
• The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI

  2012cited by this paper
• Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

  2012cited by this paper
• Postoophorectomy Estrogen Use and Breast Cancer Risk

  2012cited by this paper
• Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

  2012cited by this paper
• Treatment with hormone therapy and calcitriol did not affect depression in older postmenopausal women: no interaction with estrogen and vitamin D receptor genotype polymorphisms

  2012cited by this paper
• Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on

  2012cited by this paper
• Future long-term trials of postmenopausal hormone replacement therapy – what is possible and what is the optimal protocol and regimen?

  2012cited by this paper
• Have we come full circle – or moved forward? The Women's Health Initiative 10 years on

  2012cited by this paper
• Quality of life and the role of menopausal hormone therapy

  2012cited by this paper
• The WHI: the effect of hormone replacement therapy on fracture prevention

  2012cited by this paper
• Estrogen and progestogen effect on venous thromboembolism in menopausal women

  2012cited by this paper
• Shock, terror and controversy: how the media reacted to the Women's Health Initiative

  2012cited by this paper
• The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective

  2012cited by this paper
• Evidence-based assessment of the impact of the WHI on women's health

  2012cited by this paper
• Hormone therapy and breast cancer risk 10 years after the WHI

  2012cited by this paper
• Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials

  2012cited by this paper
• Reproductive depression

  2012cited by this paper
• Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials

  2012cited by this paper
• The Women's Health Initiative – a decade of progress

  2012cited by this paper
• Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study

  2012cited by this paper
• Vaginal Health: Insights, Views & Attitudes (VIVA) – results from an international survey

  2012cited by this paper
• Risk factors for mortality in the nurses' health study: a competing risks analysis.

  2011cited by this paper
• Cardiovascular and cancer safety of testosterone in women

  2011cited by this paper
• Gonadal Hormones and Cognitive Aging: A Midlife Perspective

  2011cited by this paper
• DHEA Replacement for Postmenopausal Women

  2011cited by this paper
• Preventing osteoporosis in symptomatic postmenopausal women

  2011cited by this paper
• Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

  2011cited by this paper
• Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

  2011cited by this paper
• Hormone therapy and recurrence of venous thromboembolism among postmenopausal women

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

  2011cited by this paper
• Vaginal DHEA to treat menopause related atrophy: a review of the evidence.

  2011cited by this paper
• Risk of venous thromboembolism by route of administration of estrogen.

  2011cited by this paper
• Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.

  2011cited by this paper
• Safety and tolerability of testosterone patch therapy for up to 4 years in surgically menopausal women receiving oral or transdermal oestrogen

  2011cited by this paper
• Short-term Hormone Therapy with Transdermal Estradiol Improves Cognition for Postmenopausal Women with Alzheimer's Disease: Results of a Randomized Controlled Trial

  2011cited by this paper
• Timing of hormone therapy and dementia: The critical window theory revisited

  2011cited by this paper
• Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids.

  2011cited by this paper
• Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

  2011cited by this paper
• Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

  2011cited by this paper
• Oestrogen is important for maintenance of cartilage and subchondral bone in a murine model of knee osteoarthritis

  2010cited by this paper
• Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

  2010cited by this paper
• Recommendations for the management of postmenopausal vaginal atrophy

  2010cited by this paper
• Action of estrogens in the aging brain: dementia and cognitive aging.

  2010cited by this paper
• Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.

  2010cited by this paper
• Bone anabolic versus bone anticatabolic treatment of postmenopausal osteoporosis

  2010cited by this paper
• Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis

  2010cited by this paper
• Hot flushes: are there effective alternatives to estrogen?

  2010cited by this paper
• Predictably Irrational: The Hidden Forces That Shape Our Decisions • Denialism: How Irrational Thinking Hinders Scientific Progress, Harms the Planet, and Threatens Our Lives

  2010cited by this paper
• Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: Sensitivity of the WHO FRAX tool

  2010cited by this paper
• Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear?

  2010cited by this paper
• Efficacy and tolerability of local estrogen therapy for urogenital atrophy

  2010cited by this paper
• Endometrial safety of ultra-low-dose Vagifem 10 μg in postmenopausal women with vaginal atrophy

  2010cited by this paper
• Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.

  2010cited by this paper
• Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition

  2010cited by this paper
• Physical activity and risk of breast cancer among postmenopausal women.

  2010cited by this paper
• Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.

  2010cited by this paper
• Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.

  2010cited by this paper
• State of the epidemiological evidence on physical activity and cancer prevention.

  2010cited by this paper
• Different mechanisms for benefit and risk of coronary heart disease and stroke in early postmenopausal women: a hypothetical explanation

  2010cited by this paper
• Transdermal hormone therapy and the risk of stroke and venous thrombosis

  2010cited by this paper
• Is there a role for estrogen in treating depression during menopause?

  2010cited by this paper
• Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis

  2010cited by this paper
• Testosterone treatment of HSDD in naturally menopausal women: the ADORE study

  2010cited by this paper
• Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy?

  2010cited by this paper
• Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe

  2010cited by this paper
• Hormone replacement therapy and the risk of venous thromboembolism: a population‐based study

  2010cited by this paper
• The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH‐AARP cohort

  2010cited by this paper
• Postmenopausal hormone therapy: an Endocrine Society scientific statement.

  2010cited by this paper
• Menopausal hormone therapy use and risk of invasive colon cancer: the California Teachers Study.

  2010cited by this paper
• DHEA for postmenopausal women: a review of the evidence.

  2010cited by this paper
• Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study

  2010cited by this paper
• Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society

  2010cited by this paper
• Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.

  2009cited by this paper
• Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials

  2009cited by this paper
• Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial

  2009cited by this paper
• Oestrogen therapy for urinary incontinence in post-menopausal women.

  2009cited by this paper
• Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women.

  2009cited by this paper
• Denialism: How Irrational Thinking Hinders Scientific Progress, Harms the Planet, and Threatens Our Lives

  2009cited by this paper
• Effects of the menopause transition and hormone use on cognitive performance in midlife women

  2009cited by this paper
• Effect of long-term testosterone administration on the endometrium of female-to-male (FtM) transsexuals.

  2009cited by this paper
• The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.

  2009cited by this paper
• Hormone Replacement Therapy: Real Concerns and False Alarms

  2009cited by this paper
• The use of estrogen therapy in women's sexual functioning (CME).

  2009cited by this paper
• Denosumab for prevention of fractures in postmenopausal women with osteoporosis.

  2009cited by this paper
• Coronary heart disease and menopause management: the swinging pendulum of HRT.

  2009cited by this paper
• Estrogens and the intervertebral disc

  2009cited by this paper
• Current and Emerging Pharmacologic Therapies for the Management of Postmenopausal Osteoporosis

  2009cited by this paper
• Raloxifene use in clinical practice: efficacy and safety

  2009cited by this paper
• Breast Cancer Risk in Postmenopausal Women Using Estradiol–Progestogen Therapy

  2009cited by this paper
• Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen

  2009cited by this paper
• Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

  2009cited by this paper

• Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?

  2025cites this paper
• Menopausal Hormone Therapy and the Risk of Stroke: A Nationwide Cohort Study

  2025cites this paper
• Physical Activity and its Correlation with Quality of Life in Perimenopausal Women: A Cross-sectional Study

  2025cites this paper
• Discrepancies in breast cancer guideline recommendations despite similar Cochrane systematic review conclusions

  2024cites this paper
• The musculoskeletal syndrome of menopause

  2024cites this paper
• Unravelling the performance of atmospheric radiative transfer schemes in the simulation of mean surface climate in Central Africa using the RegCM5 climate model

  2024cites this paper
• Efficiency and safety of acupuncture for women with premature ovarian insufficiency: study protocol for a randomized controlled trial.

  2023cites this paper
• Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective

  2023cites this paper
• Current Status of MHT Treatment for Menopausal Syndrome

  2023cites this paper
• A Simple Mathematical Model Demonstrates the Potential for Cell-Based Hormone Therapy to Address Dysregulation of the Hypothalamus-Pituitary-Ovary Axis in Females with Loss of Ovarian Function

  2023cites this paper
• Debate on the oncologic potential of sex steroid preparations

  2023cites this paper
• Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

  2023cites this paper
• Effect of vitamin D vaginal suppository on sexual functioning among postmenopausal women: A three-arm randomized controlled clinical trial

  2023cites this paper
• The effect of vitamin D on sexual function: a systematic review

  2023cites this paper
• Clinical evaluation of autologous platelet rich plasma injection in postmenopausal vulvovaginal atrophy: A pilot study

  2022cites this paper
• Modern integrated approach in the treatment of atrophic vaginitis in women of menopausal age

  2022cites this paper
• A Clinical Review on Paroxetine and Emerging Therapies for the Treatment of Vasomotor Symptoms

  2022cites this paper
• Management of genitourinary syndrome of menopause in breast cancer survivors: An update

  2022cites this paper
• The Management of Vasomotor Symptoms of Menopause (VMS) with Menopausal Hormone Therapy (MHT)

  2022cites this paper
• Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study

  2022cites this paper
• Correction of menopausal disorders: new possibilities of menopausal hormone therapy

  2022cites this paper
• The comparison of paroxetine and gabapentin in the management of postmenopausal symptoms

  2021cites this paper
• New trends in current menopausal hormone therapy

  2021cites this paper
• Impact of progesterone on skin and hair in menopause – a comprehensive review

  2021cites this paper
• Modern approaches to the management of menopause

  2021cites this paper
• A Double-Blind Randomized Sham-Controlled Trial to Evaluate the Efficacy of Fractional Carbon Dioxide Laser Therapy on Genitourinary Syndrome of Menopause.

  2021cites this paper
• Evaluation of endometrial progesterone receptor expression after 12 weeks of exposure to a low-dose vaginal estradiol insert

  2021cites this paper
• The comparison of paroxetine and gabapentin in the management of postmenopausal symptoms

  2021cites this paper
• 17β-Estradiol, Drosperinone, and UDCA Effective in Cholestasis in Early Postmenopausal Syndrome

  2021cites this paper
• The Role of Endocannabinoid System in Menopause and Its Related-Diseases

  2021cites this paper
• The association between primary ovarian insufficiency and osteoporosis in the Canadian Longitudinal Study on Aging

  2021cites this paper
• Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

  2021cites this paper
• Estradiol and mortality in women with end-stage kidney disease

  2020cites this paper
• Neurourology and Urodynamics

  2020cites this paper
• Estrategias de manejo durante el climaterio y menopausia. Guía práctica de atención rápida

  2020cites this paper
• Atherothrombotic stroke in women: blood thrombogenicity and the vascular wall

  2020cites this paper
• Applying concepts of life course theory and life course epidemiology to the study of bladder health and lower urinary tract symptoms among girls and women

  2020cites this paper
• Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence

  2020cites this paper
• The value of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia

  2020cites this paper
• The usefulness of melatonin supplementation in postmenopausal women with Helicobacter pylori-associated dyspepsia

  2020cites this paper
• Arterial palmar arch occlusion in a woman with Raynaud's disease taking oral combined menopausal hormone therapy: A case report

  2020cites this paper
• Hormone Replacement Therapy: Risks and Benefits

  2020cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2020cites this paper
• Approach to Managing a Postmenopausal Patient.

  2020cites this paper
• The changing shape of menopausal hormone therapy

  2020cites this paper
• Age-related alterations on ultrastructure and gene expression profile of the female Blood-Brain Barrier

  2020cites this paper
• The 2020 Menopausal Hormone Therapy Guidelines

  2020cites this paper
• Estradiol and mortality in women with end-stage kidney disease.

  2020cites this paper
• Endothelial Vascular Function as a Surrogate of Vascular Risk and Aging in Women.

  2020cites this paper
• THE KOREAN SOCIETY OF MENOPAUSE PAGES

  2020cites this paper
• Menopausal Therapy: Modern View of the Problem

  2020cites this paper
• Longitudinal impact of the Women’s Health Initiative study on hormone therapy use in Australia

  2019cites this paper
• Updated treatment guideline for hormone therapy in postmenopausal women

  2019cites this paper
• Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women

  2019cites this paper
• Efficacy of pharmacological and non-pharmacological interventions on low sexual interest/arousal of peri- and post-menopausal women: a meta-analysis

  2019cites this paper
• Experience of using MHT combined with dipyridamole in patients in the early postmenopause

  2019cites this paper
• Menopausal hormone therapy and cancer risks of reproductive system. Literature review

  2019cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2019cites this paper
• Bone Mineral Density and Breast Cancer Incidence and Mortality in Postmenopausal Women: A Long-Term Follow-Up Study

  2019cites this paper
• Use of hormone therapy (HT) among Swedish women with contraindications - A pharmacoepidemiological cohort study.

  2019cites this paper
• Gynecological Problems among Women on Hemodialysis

  2019cites this paper
• Systemic estradiol levels with low-dose vaginal estrogens

  2019cites this paper
• The Effect of Perimenopausal Transdermal Estradiol and Micronized Progesterone on Markers of Risk for Arterial Disease.

  2019cites this paper
• Bioidentische Hormone

  2019cites this paper
• Review of non‐invasive vulvovaginal rejuvenation

  2019cites this paper
• Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women

  2019cites this paper
• Опыт применения МГТ в сочетании с дипиридамолом у пациенток в ранней постменопаузе

  2019cites this paper
• Hormone therapy for first-line management of menopausal symptoms: Practical recommendations

  2019cites this paper
• Early onset of action with a 17β-estradiol, softgel, vaginal insert for treating vulvar and vaginal atrophy and moderate to severe dyspareunia.

  2019cites this paper
• Hormonersatztherapie (HRT) und kardiovaskuläre Folgen

  2019cites this paper
• A menopause survey of women with benign breast disease history in northwest China

  2019cites this paper
• Recommendations on menopausal hormone replacement therapy.

  2019cites this paper
• First to know

  2019influential citation
• Should women be screened for osteoporosis at midlife?

  2018cites this paper
• Structural and functional changes of blood vessels in women in early postmenopause, the possibility of correction of the revealed violations

  2018cites this paper
• CHANGES OF CARDIOMETABOLIC RISK FACTORS IN EARLY AND LONG-TERM USE OF MENOPAUZAL HORMONE THERAPY IN WOMEN OF THE CLIMACTERIC PERIOD

  2018cites this paper
• Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other risk women)

  2018cites this paper
• Treatment of Menopausal Symptoms in Breast Cancer Survivors

  2018cites this paper
• Towards optimization of estrogen receptor modulation in medicine

  2018cites this paper
• Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment

  2018cites this paper
• Postmenopausal hormone therapy and the kidney: a new target for an old treatment?

  2018cites this paper
• [Towards an optimization of the modulation of the estrogen receptor during menopausal hormonal therapy].

  2018cites this paper
• First-Night Effect on Sleep in Different Female Reproductive States

  2018cites this paper
• The impact of micronized progesterone on breast cancer risk: a systematic review

  2018cites this paper
• Menopause and hormone replacement therapy: the 2017 Recommendations of the Italian Menopause Society.

  2018cites this paper
• Androgens in postmenopausal women

  2018cites this paper
• Attitude of Postmenopausal Women Toward the Menopause and Hormone Treatment in Enugu, Southeast Nigeria

  2018cites this paper
• Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO

  2018cites this paper
• Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors

  2018cites this paper
• Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years

  2018cites this paper
• Impact of micronized progesterone on body weight, body mass index, and glucose metabolism: a systematic review

  2018cites this paper
• Menopausale Hormontherapie (MHT) bei internistischen Erkrankungen

  2018cites this paper
• What do TSECs provide in the menopausal hormone therapy?

  2018cites this paper
• Evaluation of the CO 2 Laser Therapy on Vulvo-Vaginal Atrophy ( VVA ) in Oncological Patients : Preliminary Results

  2017cites this paper
• A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy

  2017cites this paper
• The bidirectional relationship between vasomotor symptoms and depression across the menopausal transition: a systematic review of longitudinal studies

  2017cites this paper
• Usporedba transdermalne i oralne primjene hormonskog nadomjesnog liječenja kod žena u postmenopauzi

  2017cites this paper
• A summary of the influence of exogenous estrogen administration across the lifespan on the GH/IGF-1 axis and implications for bone health.

  2017cites this paper
• Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study

  2017cites this paper
• Clinical relevance of hypercoagulability and possible hypofibrinolysis associated with estrone and estriol

  2017cites this paper